Martin Jamieson

Martin Jamieson has been CEO from April 2016. Following a marketing career in the pharmaceutical industry with Wyeth (Pfizer) and 3M, Martin joined Smith Medical - part of the FTSE 100 Smiths Group - as Director and Divisional Managing Director culminating in his final position - Managing Director Smiths Medical International. He was then appointed CEO of Rayner Group, a globally based ophthalmology company which developed the first intraocular lens. Martin has a number of Non-Executive Directorships with Light Point Medical Ltd, C-Major Ltd. and Schuco Ltd. Until December 2016 Martin was a NED at Medway NHS Hospital Foundation Trust where he was Senior Independent Director, Deputy Chair and formally Audit Chair. He also consults on international market development with Rocket Medical Plc.